Executive Summary UPLAR Products in queue for over 180 days awaiting product licenses will now be issued ENs (exemption number) allowing the product to be legal for saleProducts must […] Read More >>
Dear stakeholders, As of August 9, 2010, NHPD will no longer accept Product Licence Applications (PLA) containing medicinal or non-medicinal ingredients which are not listed as acceptable ingredients in the […] Read More >>
  Dear stakeholders, The Application Management Policy outlines the way in which Product Licence Applications for natural health products are submitted in accordance with the Natural Health Products Regulations. The […] Read More >>
  Dear stakeholders, The Natural Health Products Directorate (NHPD) has received just over 4600 Site Licence Applications (SLA) since 2004. Most of which have critical evidence deficiencies that require the […] Read More >>
  Less than two weeks remain to register for dicentra’s upcoming webinar titled Good Manufacturing Practices for Natural Health Product Site Licence Holders. Health Canada requires both initial and ongoing […] Read More >>
  Watch the recording of this webinar by clicking here. The regulatory solution many have been waiting for may be on the horizon with the recent regulatory proposal: Natural Health […] Read More >>
The Sale of Unlicensed Natural Health Products, Exemption Numbers, and You! Natural Health Products (Unprocessed Product Licence Applications) Regulations The regulatory solution many have been waiting for may be on […] Read More >>
    Michelle Boudreau Director General, Natural Health Products Directorate, Health Canada Accomplishments & Looking Ahead Approximately 20,700 product licenses issued since 2004, representing ~27,000 products More than 1,150 companies [&hell Read More >>
  As you may know, the Natural Health Product (NHP) Raw Material Policy was recently removed from the Natural Health Products Directorate (NHPD) website in order for it to be […] Read More >>
  From the Canadian Health Food Association (CHFA) eNews April 30th edition: Great News for NHP Industry Draft regulatory amendment to be published in Canada Gazette Part I CHFA has […] Read More >>
  Anne Wilkie, Senior Regulatory Strategy & Policy Advisor, will be representing Dicentra at the International Pharmaceutical Academy’s Dietary Supplements & Natural Health Products Conference in Montreal on April 21 […] Read More >>
Industry News: The Sale of Unlicensed NHPs Background While the NHPD is making progress on the massive number of Product License Applications (PLAs) they have received, there are still thousands […] Read More >>
  Many products fall under the cosmetic-drug interface. These are products that may share the characteristics of both a cosmetic and drug, as defined in the Food and Drugs Act, […] Read More >>
  Dear Stakeholders, The Natural Health Products Directorate (NHPD) is pleased to announce that the Licensed Natural Health Products Database (LNHPD) extract files are now available for downloading from Health […] Read More >>
The Debate Surrounding the Sale of Unapproved Natural Health Products Continues Despite Health Canada adopting a risk-based enforcement policy until at least March 31 in acknowledgment of the Product License […] Read More >>
  On January 26th, 2010, Health Canada’s Natural Health Products Directorate (NHPD) has issued a draft warning letter concerning Natural Health Products containing glucomannan, an ingredient authorized for the purposes […] Read More >>
  The NHPD Issues a Message to NHP Stakeholders Regarding Ezymes December 14, 2009 Le texte français suit. The Natural Health Products Directorate (NHPD) has received over 500 product licence […] Read More >>
Health Canada’s recent workshop series took some of the pressure off industry members with regards to the March 2010 deadline and the backlog of product license applications (PLAs) still awaiting […] Read More >>
  It seems without a doubt that increasing global regulatory requirements for natural health products are here to stay. International bodies such as the NHPD (Canada), FDA (U.S.), EMEA/EFSA (European […] Read More >>
  The Food and Drug Administration (FDA) and Federal Trade Commission (FTC) are warning consumers to be wary of products which claim to diagnose, prevent, mitigate, treat or cure the […] Read More >>